A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home AIMD Business Boston Scientific’s Active Implantable Sales for 2011: CRM Down 7%, Neuromodulation Up 10%
formats

Boston Scientific’s Active Implantable Sales for 2011: CRM Down 7%, Neuromodulation Up 10%

Boston Scientific Logo

Today Boston Scientific Corporation announced financial results for the fourth quarter and full year ended December 31, 2011.  Summarizing the AIMD data:

  • On a constant-currency basis, Q4 2011 CRM sales were $482M compared to $564M in Q4 2010, or  down 15%
  • On a constant-currency basis, 2011 CRM sales were $2,087M compared to $2,180M in Q4 2010, or  down 7%
  • On a constant-currency basis, Q4 2011 Neuromodulation sales were $91M compared to $86M in Q4 2010, or  up 6%
  • On a constant-currency basis, Q4 2011 CRM sales were $336M compared to $304M in Q4 2010, or  up 10%

Click here for the news release.

 

 

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific’s Active Implantable Sales for 2011: CRM Down 7%, Neuromodulation Up 10%  comments